New award for montelukast NA tablets with xlcare pharmaceuticals, INC. Period of performance may 10, 2021 through may 9, 2022 with four one year options.
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79721D0027
- Awardee
-
Xlcare Pharmaceuticals Inc. UEI MEAUS5WHBJJ7
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Montelukast Tablets (VA-21-00012958) Pre-Solicitation · 36E79721R0011 · Posted Dec 2, 2020
- 6505--Montelukast Tablets (VA-21-00012958) Effective 5/10/2021 - 5/9/2022 Award Notice · Posted Mar 10, 2021
- 6505--Montelukast Tablets (VA-21-00012958) Solicitation · Posted Dec 23, 2020
- Last date to order 100% complete
- IDV ceiling
- $23,863,543.01
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 4 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
This single-award Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) National Acquisition Center to Xlcare Pharmaceuticals Inc. for the supply of Montelukast NA Tablets. The contract has a 1-year base period with four 1-year option periods, for a total potential period of performance through May 9, 2026. The contract ceiling value is $23,863,543.01.
The contract aims to provide an uninterrupted source of Montelukast NA Tablets in various package sizes to the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. The solicitation was open to all responsible sources, with no set-aside designation. Xlcare Pharmaceuticals, a minority-owned, small disadvantaged business, was awarded the single-award IDC to supply the estimated annual requirements of approximately 175,261 bottles of 30-count, 798,117 bottles of 90-count, and 30,183 bottles of 1,000-count Montelukast NA 10mg Tablets. The pharmaceutical products will be distributed through the VA's and DoD's respective Pharmaceutical Prime Vendor Programs.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79721D0027?
36E79721D0027 was awarded to Xlcare Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on May 10, 2021.
How much is contract 36E79721D0027 worth?
36E79721D0027's own ceiling is $23,863,543.
Who can order from contract 36E79721D0027?
36E79721D0027 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36E79721D0027 competed?
The extent of competition for 36E79721D0027 was full and open competition. The government received 4 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV